Group IVA cytosolic phospholipase A 2 (cPLA 2 ) has been shown to play a critical role in the agonist-induced release of arachidonic acid. To understand the mechanism by which phosphorylation of Ser 505 and Ser 727 activates cPLA 2 , we systematically analyzed the effects of S505A, S505E, S727A, S727E, S505A/S727A, S505A/S727E, and S505E/S727E mutations on its enzyme activity and membrane affinity. In vitro membrane binding measurements showed that S505A has lower affinity than the wild type or S505E for phosphatidylcholine membranes, which is exclusively due to faster desorption of the membrane-bound S505A. In contrast, neither S727A nor S727E mutation had a significant effect on the phosphatidylcholine vesicle binding affinity of cPLA 2 . The difference in in vitro membrane affinity between wild type (or S505E) and S505A increased with the decrease in Ca 2؉ concentration, reaching >60-fold at 2.5 M Ca 2؉ . When HEK293 cells transfected with cPLA 2 and mutants were stimulated with ionomycin, the wild type and S505E translocated to the perinuclear region and caused the arachidonic acid release at 0.4 M Ca 2؉ , whereas S505A showed no membrane translocation and little activity to release arachidonic acid. Further mutational analysis of hydrophobic residues in the active site rim (Ile 399 , Leu 400 , and Leu 552 ) indicate that a main role of the Ser 505 phosphorylation is to promote membrane penetration of these residues, presumably by inducing a conformational change of the protein. These enhanced hydrophobic interactions allow the sustained membrane interaction of cPLA 2 in response to transient calcium increases. On the basis of these results, we propose a mechanism for cPLA 2 activation by calcium and phosphorylation.
Group IVA cytosolic phospholipase A 2 (cPLA 2 ) has been shown to play a critical role in the agonist-induced release of arachidonic acid. To understand the mechanism by which phosphorylation of Ser 505 and Ser 727 activates cPLA 2 , we systematically analyzed the effects of S505A, S505E, S727A, S727E, S505A/S727A, S505A/S727E, and S505E/S727E mutations on its enzyme activity and membrane affinity. In vitro membrane binding measurements showed that S505A has lower affinity than the wild type or S505E for phosphatidylcholine membranes, which is exclusively due to faster desorption of the membrane-bound S505A. In contrast, neither S727A nor S727E mutation had a significant effect on the phosphatidylcholine vesicle binding affinity of cPLA 2 . The difference in in vitro membrane affinity between wild type (or S505E) and S505A increased with the decrease in Ca 2؉ concentration, reaching >60-fold at 2.5 M Ca 2؉ . When HEK293 cells transfected with cPLA 2 and mutants were stimulated with ionomycin, the wild type and S505E translocated to the perinuclear region and caused the arachidonic acid release at 0.4 M Ca 2؉ , whereas S505A showed no membrane translocation and little activity to release arachidonic acid. Further mutational analysis of hydrophobic residues in the active site rim (Ile 399 , Leu 400 , and Leu 552 ) indicate that a main role of the Ser 505 phosphorylation is to promote membrane penetration of these residues, presumably by inducing a conformational change of the protein. These enhanced hydrophobic interactions allow the sustained membrane interaction of cPLA 2 in response to transient calcium increases. On the basis of these results, we propose a mechanism for cPLA 2 activation by calcium and phosphorylation.
Phospholipases A 2 (PLA 2 )
1 catalyze the hydrolysis of the sn-2 ester of membrane phospholipids, the products of which can be transformed into potent inflammatory lipid mediators, including platelet-activating factor and eicosanoids. Among multiple forms of PLA 2 s found in mammalian tissues, the 85-kDa group IVA PLA 2 (cPLA 2 ) has been shown to play a key role in the agonist-induced release of arachidonic acid (AA) that acts as a precursor to eicosanoids (1) (2) (3) . A central role of cPLA 2 in agonist-induced AA release, which is in line with its ubiquitous distribution in mammalian tissues, has been demonstrated by recent studies using cPLA 2 -deficient mice (4, 5) .
Cellular cPLA 2 activities are tightly regulated by different factors, including Ca 2ϩ and phosphorylation (1) (2) (3) . It has been well established that calcium binds to the amino-terminal C2 domain (6) and drives its membrane binding in vitro (7) (8) (9) and in the cell (10, 11) . Phosphorylation has also been shown to activate cPLA 2 , but this regulatory mechanism appears to be complex. It was initially found that the phosphorylation of Ser 505 by mitogen-activated protein kinases is essential for agonist-induced AA release in Chinese hamster ovary cells (12) . Further studies have shown, however, that the effect of Ser 505 phosphorylation on agonist-induced AA release is cell type-and agonist-dependent. For instance, Ser 505 phosphorylation of cPLA 2 is not required for the AA release in thrombinstimulated platelets (13) . In macrophages, Ser 505 phosphorylation is not essential for AA release in response to agonists that induce a sustained increase in calcium, but appears to be important when there is a transient increase in calcium (14) . The phosphorylation analysis of cPLA 2 expressed in baculovirus-infected insect Sf9 cells showed that the protein is phosphorylated on multiple Ser residues, including Ser 454 , Ser 437 , Ser 505 , and Ser 727 (15) . It was reported that among these sites, Ser 454 , Ser 437 , and Ser 505 are constitutively phosphorylated in unstimulated Sf9 cells but that only Ser 505 phosphorylation partially contributes to cPLA 2 activation (11) . Subsequent studies with human platelets, HeLa, and human embryonic kidney (HEK) 293 cells indicated that Ser 505 and Ser 727 are phosphorylated in response to agonists and that phosphorylation of both sites plays an important role in agonist-induced AA release (16, 17) . More recently, it was reported that phosphorylation of Ser 515 by calcium/calmodulin-dependent protein kinase II in vascular smooth muscle cells increased the enzymatic activity of cPLA 2 (18) . Finally, it has been suggested that phosphatidylinositol 4,5-bisphosphate can specifically activate cPLA 2 (19, 20) by inducing conformational changes of the enzyme and thereby juxtaposing its active site and the membrane surface (20) .
Although much is known about the sites of cPLA 2 phosphorylation, the agonists and the protein kinases that cause cPLA 2 phosphorylation, and the effects of cPLA 2 phosphorylation on agonist-induced AA release, little is known about the mechanism by which cPLA 2 phosphorylation activates the enzyme. Also, it is poorly understood how calcium, phosphorylation, and potentially phosphatidylinositol 4,5-bisphosphate work in con-cert to achieve the subcellular targeting and the activation of cPLA 2 . This study is undertaken to address these questions with an emphasis on phosphorylation of Ser 505 2 -Baculovirus transfer vectors encoding the cDNAs of cPLA 2 with appropriate phosphorylation site mutations were generated by the overlap extension PCR using the plasmid pVL1392-cPLA 2 (21) as a template. Transfection of Sf9 cells with mutant pVL1392-cPLA 2 constructs was performed using the BaculoGold TM transfection kit from Pharmingen. Plasmid DNA for transfection was prepared using an EndoFree Plasmid Maxi kit (Qiagen, Valencia, CA) to avoid possible endotoxin contamination. For protein expression, Sf9 cells were grown to 2 ϫ 10 6 cells/ml in 350-ml suspension cultures and infected with high titer recombinant baculovirus at a multiplicity of infection of 10. The cells were then incubated for 3 days at 27°C. For harvesting, cells were centrifuged at 1000 ϫ g for 10 min and resuspended in 35 ml of extraction buffer (20 mM Tris-HCl, pH 7.5, containing 0.1 M KCl, 1 mM EDTA, 20% (v/v) glycerol, 10 g/ml leupeptin, and 1 mM phenylmethanesulfonyl fluoride). The suspension was homogenized in a hand-held homogenizer chilled on ice. The extract was centrifuged at 100,000 ϫ g for 1 h at 4°C. To the supernatant, 1 ml of nickel-nitrilotriacetic acid-agarose (Qiagen, Valencia, CA) was added, and the mixture was kept shaking at 100 rpm for 1 h. The protein was purified according to the manufacturer's protocol. cPLA 2 fractions were concentrated and desalted in an Ultrafree-15 centrifugal filter device (Millipore, Bedford, MA). Protein concentration was determined by the bicinchoninic acid method (Pierce).
In Vitro cPLA 2 Activity Assay-Activity of cPLA 2 was assayed by measuring the initial rate of [ 14 C]SAPC hydrolysis as described (22) . Assay mixtures (50 l) contained small unilamellar vesicles of [ Free calcium concentration was adjusted using a mixture of EGTA and CaCl 2 according to the method of Bers (23) . Reactions were started by adding cPLA 2 to the mixture (to a final concentration of ϳ10 nM) and quenched by adding 370 l of chloroform/methanol/HCl (2:1:0.01, v/v/v) solution after a given period of incubation (2-4 min) at room temperature. Liberated [ 14 C]AA was separated from the reaction mixture on small silica gel columns, and the radioactivity was measured by liquid scintillation counting.
Surface Plasmon Resonance Analysis-Membrane binding kinetics was measured by surface plasmon resonance (SPR) analysis using a BIAcore X biosensor system and a Pioneer L1 sensor chip (Biacore, AB) as described previously (24) . The control surface was coated with 1000 resonance unit (RU) of BSA. The sensor surface was coated with extruded large unilamellar vesicles of DHPC at a flow rate of 5 l/min until the RU reached 2000. After lipid coating, 30 l of 50 mM NaOH was injected at 100 l/min to remove loosely bound vesicles. Typically, no further decrease in SPR signal was observed after one wash cycle. To probe for any uncovered surface, the flow cell was subjected to a 5-min injection of 0.1 mg/ml BSA. After coating, the drift in signal was allowed to stabilize below 0.3 RU/min before any kinetic experiments were done. Analyses were performed at 23°C and at a flow rate of 60 l/min. Ninety microliters of protein sample was injected for the association time of 90 s, although the dissociation was monitored for 4 min in the running buffer. After each protein injection, the lipid surface was regenerated with a 10-l pulse of 50 mM NaOH. The regeneration was repeated until the SPR signal reached the initial background value before the next protein injection. Typically, a set of binding data include five or more protein concentrations (typically 10-fold range above or below K d ), each measured in triplicate. After each set of measurements, the entire sensor surface was removed with a 5-min injection of 40 mM CHAPS followed by a 5-min injection of 40 mM octyl-␤-D-glucopyranoside at 5 l/min, and the sensor chip was recoated for the next set of experiments. For each trial, the signal was corrected against the control surface in order to eliminate any refractive index changes due to buffer change. Furthermore, the derivative plot was used to monitor potential mass transport effects. Once these factors were checked for each set of data, the association and the dissociation phases of all sensorgrams were globally fit to a 1:1 Langmuir binding model: protein ϩ (proteinbinding site on the vesicle) 7 (complex) using BIAevaluation 3.0 software (Biacore). The association phase was analyzed by using Equation 1,
where RI is the refractive index change; R max is the theoretical binding capacity; C is the protein concentration; k a is the association rate constant; and t 0 is the initial time. The dissociation phase was analyzed by using Equation 2,
where k d is the dissociation rate constant, and R 0 is the initial response. The dissociation constant (K d ) was then calculated from the equation, Lipid-coated Bead Binding Measurements-The binding of cPLA 2 and mutants to DHPC was measured by a sedimentation assay using DHPC-coated hydrophobic styrene-divinylbenzene beads as described previously (25, 26) . Binding mixtures contained a fixed concentration of DHPC-coated beads (1 M) in 20 mM Tris-HCl buffer, pH 7.4, containing 0.16 M KCl, 1 M BSA, and varying concentrations of cPLA 2 (10 -200 nM) . After the mixtures were incubated for 15 min, beads were pelleted (12,000 ϫ g for 2 min), and the free protein amount was determined by activity assay using SAPC as substrate. Parameters n and K d were determined by non-linear least squares analysis of the bound ([P] b ) versus total protein concentration ([P] 0 ) plot using a standard binding equation, Equation 3 (25) ,
where [PL] 0 represents total phospholipid concentration. This equation assumes that each enzyme binds independently to a site on the interface composed of n phospholipids with dissociation constant of K d .
Cell Culture, Transfection, and Protein Production-The vectors for amino-terminal enhanced green fluorescence protein (EGFP) fusion cPLA 2 and mutants were generated as described previously (20) . A stable HEK293 cell line expressing the ecdysone receptor (Invitrogen) was used for all cell studies. Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37°C in 5% CO 2 and 98% humidity until 90% confluent. Cells between the 5th and 20th passage were passaged into 8 wells of a Lab-Tech TM chambered coverglass. For transfection, these cells were exposed to 150 l of unsupplemented DMEM containing 0.5 g of endotoxin-free DNA and 1 l of LipofectAMINE TM reagent (Invitrogen) for 7-8 h at 37°C. After exposure, the transfection medium was removed, and the cells washed once with FBS-supplemented DMEM and overlaid with FBS-supplemented DMEM containing Zeocin TM and 140 g/ml Ponasterone A to induce protein production.
Confocal Microscopy-Protein translocation and the intracellular calcium concentration ([Ca 2ϩ ] i ) were simultaneously monitored using a four-channel Zeiss LSM 510 laser scanning confocal microscope. All experiments were carried out at the same laser power, which was found to induce minimal photobleaching over 30 scans, and at the same gain and offset settings on the photomultiplier tube. Also, a ϫ63, 1.2 numerical aperture water immersion objective was used for all experiments. EGFP was excited using the 488-nm line of an argon/krypton laser and a linepass 505-nm filter was used to monitor EGFP emission. Fura-Red and mag-indo-1 were used to determine [Ca 2ϩ ] i in the submicromolar and micromolar ranges, respectively. Fura-Red was excited using the 488-nm line of argon/krypton laser, and the emitted light was collected using a 585-nm linepass filter. Mag-indo-1 was excited using the 340-nm line of the UV laser, and the emitted light was collected using bandpass filters (395-425 and 450 -490 nm).
Membrane Translocation of cPLA 2 -Thirty minutes before imaging, cells were treated with 2 l of Fura-Red or Mag-indo-1 (10 M final concentration). Immediately before imaging, the induction media were removed, and the cells were washed with 150 l of 2 mM EGTA and then overlaid with 150 l of HEK buffer (1 mM HEPES, pH 7.4, containing 2.5 mM MgCl 2 , 1 mM NaCl, 0.6 mM KCl, 0.67 mM D-glucose, 6.4 mM sucrose). After initially imaging cells, 150 l of HEK buffer containing 2-10 M ionomycin and 1 mM CaCl 2 was added to cells for a sustained increase in [Ca 2ϩ ] i , and cPLA 2 translocation was monitored by time scanning at 15-s intervals. For a transient increase in [Ca 2ϩ ] i , 150 l of HEK buffer containing 5 M ionomycin and 0.5 mM Ca 2ϩ (final concentration) was added to the cells, and cPLA 2 translocation was monitored over time. Once cPLA 2 and mutants have been translocated to the nuclear envelope (typically ϳ10 min), 100 l of HEK buffer containing 5 mM EGTA (final concentration) was added, and cells were imaged.
Images were analyzed using the analysis tools provided in the Zeiss biophysical software package. By using these tools, regions of interest in the cytosol were defined, and the average intensity in a square (1 ϫ 1 mm) obtained with time. Membrane intensities were determined for each frame in individual cells by extending a line from the cytosol to the outside of the cell and reading off the intensity with distance along the line. By cross-checking markers on the diagram with a table of intensity data, four intensity values corresponding to the place on the line indicating the edge of the cell were averaged. Lines were drawn in at least three places in each cell, and membrane intensity values were determined and averaged. The resultant intensity values were converted to a ratio of intensity at membrane to the sum of intensities at membrane and at cytosol for each time frame. These values were plotted for the entire time course (see Fig. 4 ).
[Ca 2ϩ ] i Determination-For calcium imaging with Fura-Red, the regions of interest in the cytoplasm were defined, and the fluorescence intensity at a given time was measured for at least five different points and averaged (F). The fluorescence intensity at saturating calcium concentration (F max ) was determined by adding 10 M ionomycin. Similarly by adding 50 M 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid-acetoxymethyl ester to the cells, the fluorescence intensity at zero free calcium (F min ) was determined. [Ca 2ϩ ] i was then calculated using the formula: (27) , where K ca (140 nM) is the calcium dissociation constant of Fura-Red (28) .
With mag-indo-1, [Ca 2ϩ ] i in the cytoplasm was ratiometrically determined at 4 -15-s intervals using the equation [Ca 2ϩ (27) , where R represents the fluorescence intensity ratio F 410 /F 470 that was determined from the average backgroundcorrected pixel values of mag-indo-1 fluorescence from the cytoplasmic area of individual cells at 410 and 470 nm, respectively; R min and R max correspond to minimum and maximum fluorescent intensity ratio at no Ca 2ϩ and saturating calcium levels (i.e. 1 mM free Ca 2ϩ ), respectively. Q is the ratio of the minimum fluorescence intensity at zero free calcium (F min ) to the maximum fluorescence intensity at 1 mM saturating calcium (F max ) at 470 nm, and K ca is the calcium dissociation constant for mag-indo-1. R min , R max , Q, and K ca values were determined by in vitro calcium calibration using 1 M mag-indo-1 and a set of standard calcium buffers (Molecular Probes) containing 0 to 1 mM free Ca 2ϩ . The calculated K ca (34 Ϯ 1 M) was the same as the reported value of 35 M (28).
Arachidonate Release from HEK293 Cells-HEK293 cells transiently transfected with cPLA 2 and its phosphorylation mutants were radiolabeled with 0.1 Ci/ml [ 3 H]AA, although the protein expression was induced. After 20 h at 37°C, the medium was removed, and cells were washed three times with the HEK buffer and then stimulated with 2-10 M ionomycin and 1.0 mM Ca 2ϩ in 0.5 ml of the same buffer solution containing 1% BSA. Because ionomycin was added as a dimethyl sulfoxide solution, the control experiment was done by stimulation with dimethyl sulfoxide. After cell activation, the supernatant was collected and briefly centrifuged to remove the cell pellet, and a 250-l aliquot was subjected to scintillation counting. Also the cells were removed from the plate by applying 200 l of trypsin-EDTA. Cells were collected by brief centrifugation, resuspended in 150 l of HEK buffer solution, and subjected to scintillation counting to determine total radioactivity of labeled cells. The AA release into the medium was then expressed in terms of the percentage of total counts of the cell.
Immunoblotting-Aliquots of HEK293 cells (2 ϫ 10 6 cells/sample) were centrifuged at 13,000 ϫ g for 20 s, and cell pellets were lysed by the addition of the ice-cold lysis buffer (20 mM Tris-HCl, pH 8.0, containing 5 mM EDTA, 40 mM NaCl, 30 mM Na 4 P 2 O 7 , 10 g/ml leupeptin, 5 g/ml aprotinin, 5 g/ml chymostatin, 2 mM diisopropyl fluorophosphate, 1 mM phenylmethylsulfonyl fluoride, 2 mM Na 3 VO 4 , 50 mM NaF, and 5 g/ml pepstatin, 1% Nonidet P-40, and 0.5% deoxycholic acid). After 20 min on ice, the samples were centrifuged (13,000 ϫ g, 10 min) to remove nuclear and cellular debris. Supernatants were mixed with the gel loading buffer (0.125 M Tris-HCl, pH 6.8, 20% (v/v) glycerol, 4% SDS, 0.005% bromphenol blue) and boiled for 5 min. Aliquots of supernatants were loaded onto 8% SDS-PAGE. The volume of each supernatant was adjusted so that cPLA 2 bands in the gel showed comparable densities. Electrotransfer of protein from the gel to the polyvinylidene fluoride membrane was achieved using a semidry system (400 mA, 60 min). The membrane was blocked with 3% BSA for 60 min and then incubated with either the anti-cPLA 2 antibody for total cPLA 2 determination or the anti-Ser 505 -phospho-cPLA 2 antibody to detect the Ser 505 -phospho-cPLA 2 . Immunocomplexes were assayed by an enhanced chemiluminescence system (Amersham Biosciences).
Determination of Phosphorylated cPLA 2 by Mass Spectrometry-The recombinant cPLA 2 (or mutant) band was excised from an SDS-PAGE gel and digested with 12.5 ng/l sequencing grade trypsin (Promega) followed by further digestion of the tryptic peptides with 20 ng/l Asp-N endopeptidase (Roche Applied Science). Digested samples were pooled, concentrated in a SpeedVac (Savant), and pressure-loaded onto a fused silica microcapillary C18 column (Magic beads, Michrom BioResources) packed in-house (75 m inner diameter, 10 cm long). An Agilent 1100 high performance liquid chromatography system (Agilent Technologies) was used to deliver a gradient across a flow splitter to the column. Eluting peptides from the column were ionized by electrospray ionization and analyzed by an LCQ-Deca ion-trap mass spectrometer (ThermoFinnigan). Peptide ions were dynamically selected by the operating software for fragmentation. Phosphoryl-containing peptides were identified by a neutral loss of 98 Da (the phosphate plus water) during the second mass analysis. The peptide fragmentation spectra were then matched with the cPLA 2 sequence using the Sequest computer algorithm (29) . For searching serine phosphorylation sites, a differential modification of ϩ80 Da on serine was included in the search parameters. 2 -It has been reported that the phosphorylation of cPLA 2 results in about 2-fold increase in enzyme activity (12, 30, 31) . In this study, we investigated how phosphorylation on Ser 505 and Ser 727 contributes to cPLA 2 activation, because the phosphorylation on these residues was shown to have the most profound effect on agonist-induced AA release by cPLA 2 in mammalian cells (16, 17) . It has been reported that cPLA 2 isolated from unstimulated Sf9 cells is constitutively phosphorylated on Ser 505 but not on Ser 727 (15) . To determine the extent of Ser 505 and Ser 727 phosphorylation for cPLA 2 expressed in Sf9 cells under our experimental conditions, we analyzed the recombinant wild type and the S505A mutant by mass spectrometry. The full-length proteins separated on and excised from the polyacrylamide gel were digested by proteases, and the peptide fragments were analyzed by liquid chromatography tandem mass spectrometry. Phosphoryl-containing peptides were identified by a neutral loss of 98 Da for the phosphate group plus water during the second mass analysis and differential mass of ϩ80 Da relative to the theoretical mass of unphosphorylated peptides. In this way we identified two peptides of different length containing the phosphorylated Ser 505 (Asn  497 to Ser   508 and Thr 500 to Ser 508 ) for wild type cPLA 2 . In both cases, the analysis of the y-and b-ion fragmentation series revealed the presence of a phosphate group at Ser 505 . Fig. 1 shows the tandem mass spectrum of a shorter phosphopeptide. The mass peaks corresponding to the peptide fragments containing unphosphorylated Ser 505 were also found, but they were much smaller than those of the Ser 505 -phosphorylated peptide in terms of ion count (Ͻ5%), indicating that the wild type is largely phosphorylated on Ser 505 . For the S505A mutant, no phosphoryl-peptide was detected. A similar peptide mapping of Ser 727 -containing peptide revealed that both wild type and S505A had a low level of phosphorylation on Ser 727 (data not shown), although accurate quantitation was difficult due to the lack of an internal standard. cPLA 2 has other potential phosphorylation sites, including Ser 437 , Ser 454 , and Ser 515 . During the tandem mass spectrometry analysis of wild type, the peaks corresponding to other phosphorylated peptides were not detected (data not shown). Thus, it appears that cPLA 2 expressed in Sf9 cells has a high degree of phosphorylation on Ser 505 and a much lower degree of phosphorylation on Ser 727 . Similarly, no trace of phosphorylated peptides was detected for S505A and S505E except for the low level of Ser 727 -phosphorylated peptide, suggesting that the mutation on the Ser 505 does not affect the levels of phosphorylation at other residues.
RESULTS

Phosphorylation Analysis of Recombinant cPLA
Membrane Affinities of Phosphorylation Site Mutants-To preclude the ambiguity associated with the partial phosphorylation of the two sites, Ser 727 in particular, we prepared a panel of mutants that mimic phosphorylated (S505E and S727E) and de-phosphorylated forms (S505A and S727A) of cPLA 2 , respectively. To investigate how phosphorylation on one site affects that of the other site, we also prepared double-site mutants, S505A/S727A, S505A/S727E, and S505E/S727E. Interfacial catalysis of PLA 2 differs from conventional enzyme catalysis in that it involves interfacial binding in addition to catalytic steps (32) . For this reason, a conventional Michaelis-Menten kinetic analysis of wild type and mutants would not yield meaningful kinetic parameters that provide insights into the mechanism of cPLA 2 activation by phosphorylation. We therefore took an approach of separately analyzing interfacial binding and catalytic steps for the wild type and the mutants to unambiguously sort out the effects of phosphorylation on different stages of interfacial catalysis.
To assess the effects of cPLA 2 phosphorylation on its interfacial binding, we first determined the affinity of wild type and mutants for non-hydrolyzable DHPC vesicles immobilized on the sensor chip by SPR analysis. The SPR analysis allows the direct determination of k a and k d , and these parameters provide insights into how different factors modulate kinetics of membrane-protein interactions (24, 25) . PC membranes were selected for this study because cPLA 2 has higher affinity for PC membranes than for anionic membranes (19, 20) . membrane affinity between S505E (or wild type) and S505A was seen at a lower Ca 2ϩ concentration than at 50 M Ca 2ϩ . For instance, reducing the Ca 2ϩ concentration from 50 to 10 M lowered the membrane affinity of S505E (or wild type) and S505A by 2.7-and 4-fold, respectively, resulting in a 4.6-fold difference in affinity for DHPC between S505E (or wild type) and S505A at 10 M Ca 2ϩ . A more dramatic difference in membrane affinity between S505E and S505A was seen at 2.5 M Ca 2ϩ . All S505A mutants showed no detectable affinity for DHPC vesicles at 2.5 M Ca 2ϩ with the protein concentration up to 5 M, indicating that K d values for the S505A mutants are Ͼ Ͼ5 M under these conditions. Consequently, S505A (and other mutants carrying S505A mutation) had Ͼ Ͼ60-fold lower affinity for DHPC vesicles than S505E (or wild type) at 2.5 M Ca 2ϩ . This suggests that under physiological submicromolar Ca 2ϩ concentrations, phosphorylation on Ser 505 would have a dramatic effect on the membrane affinity of cPLA 2 . Taken together, these binding measurements establish that the phosphorylation of Ser 505 has a direct positive effect on the interfacial binding of cPLA 2 , on the kinetics of membrane dissociation in particular.
Cellular Membrane Affinities and Activities of Phosphorylation Site Mutants-To test if the Ser 505 phosphorylation also enhances the affinity of cPLA 2 for cellular membranes, we monitored by time lapse confocal microscopy the subcellular translocation of EGFP-tagged cPLA 2 and mutants expressed in HEK293 cells. To show that the EGFP tags have no significant effect on the membrane affinity of proteins, we expressed EGFP-tagged wild type and S505A and measured their affinity for DHPC vesicles by the SPR analysis. Results showed that the vesicle affinity of these constructs is comparable (i.e. less than 10% difference) to that of their His 6 -tagged counterparts used in the in vitro membrane binding studies. Endogenous cPLA 2 expressed in HEK293 cells was undetectable by our Western analysis (data not shown), and thus the background cPLA 2 activity due to the endogenous enzyme was negligible under our experimental conditions. Wild type cPLA 2 expressed in HEK293 cells was found phosphorylated on Ser 505 when cells were cultured in DMEM containing 10% FBS (see Fig. 2 ). Because the extent of phosphorylation on Ser 505 was difficult to evaluate from these measurements, we mainly compared the properties of S505E and S505A to determine the effect of Ser 505 phosphorylation on the cellular activities of cPLA 2 .
HEK293 cells did not spontaneously respond to typical calcium agonists, such as ATP. For this reason, [Ca 2ϩ ] i was raised by adding different concentrations of Ca 2ϩ ionophore, ionomycin, in the presence of extracellular Ca 2ϩ in our cell studies, which resulted in the sustained elevation of [Ca 2ϩ ] i (Fig. 4, A  and B) . As shown in Fig. 3A , wild type, S505A, S505E, S727A, and S727E all translocated to the perinuclear region at 50 M [Ca 2ϩ ] i . Fig. 4A shows that their membrane translocation was synchronized with a rise in [Ca 2ϩ ] i , and their estimated rates of translocation were essentially the same. When [Ca 2ϩ ] i was adjusted to 0.4 M, cPLA 2 , S505E, S727A, and S727E still translocated to the perinuclear region, albeit significantly slowly; however, S505A showed no detectable migration to the perinuclear region (Figs. 3B and 4B ). Only when [Ca 2ϩ ] i was further raised by adding 10 M ionomycin, S505A spontaneously translocated to the perinuclear region (Fig. 3B) .
We then measured the AA release from [ 14 C]AA-radiolabeled Proteins ] i , however, S505A showed only the basal activity, whereas wild type and S505E released up to 3.5 times more AA than the control (Fig. 5B ). In conjunction with the drastically low efficiency of S505A to translocate to the perinuclear region at 0.4 M [Ca 2ϩ ] i , these activity data support the notion that the phosphorylation on Ser 505 greatly enhances the cellular activity of cPLA 2 at physiologically relevant submicromolar Ca 2ϩ concentrations by improving its affinity for perinuclear membranes. Interestingly, S727A also showed much reduced AA releasing activity than wild type at 0.4 M [Ca 2ϩ ] i (Fig. 5B ). This suggests that Ser 727 is normally phosphorylated during ionophore treatment. Because S727A translocated to the perinuclear region similarly to the wild type and S727E at 0.4 M [Ca 2ϩ ] i , this suggests that the Ser 727 phosphorylation regulates the cellular activity of cPLA 2 by a distinct mechanism. The observed differences in cPLA 2 activity at low [Ca 2ϩ ] i were not due to different protein expression levels, as the Western blotting of cell extracts (Fig. 5C ) showed comparable expression of S505E, S505A, and S727A.
Effects of Ser 505 Phosphorylation on Catalytic Steps-To determine directly the effect of Ser 505 phosphorylation on catalytic steps, it is necessary to perform kinetic measurements using a water-soluble substrate for cPLA 2 . Because a specific water-soluble substrate for cPLA 2 is not available at present, one can alternatively perform an activity assay under the condition in which most of enzyme molecules are membranebound. This so-called scooting mode kinetics has been performed by employing vesicles made of a synthetic lipid for which PLA 2 has high affinity (32) . In our study, we measured the enzyme activity with increasing concentrations of SAPC in vesicles (with a fixed concentration of protein) to the point in which a majority of enzymes are membrane-bound. To determine the degree of membrane binding of cPLA 2 and mutants under our kinetic assay conditions, we first determined their binding affinity (n and K d values; see under "Experimental Procedures") for DHPC coated on the hydrophobic beads. Notice that our SPR analysis only determines K d values and nK d is the dissociation constant in terms of molarity of lipid monomers from which one can assess the degree of membrane binding of a protein at given protein and lipid concentrations (see under "Experimental Procedures"). We showed previously (25, 26 ) that a sedimentation assay using PC-coated beads is advantageous over the assay using sucrose-loaded PC vesicles in determining the PC affinity of PLA 2 due to superior pelleting efficiency of PC-coated beads. The binding isotherms for cPLA 2 wild type and mutants at 50 M Ca 2ϩ are illustrated in Fig. 6 , and the values of n and K d for wild type and mutants calculated from curve fitting are listed in Table II . First of all, S505A has a 2.4-fold higher K d value than wild type, S505E, S727A, and S727E at 50 M Ca 2ϩ , which is consistent with our SPR data and thereby validating our approach of determining K d from kinetic SPR measurements. Furthermore, n values remain essentially constant for all proteins, underscoring the validity of assessing the relative membrane affinity of mutants based on their K d values alone (see above and Table I) .
We then determined the specific activities of wild type and mutants with 0.5-50 M SAPC in vesicles at fixed protein (10 nM) and Ca 2ϩ (50 M) concentrations. As shown in Fig. 7 , the wild type (8.0 Ϯ 1.5 nmol/mg min) had Ͼ2-fold higher activity than S505A (3.0 Ϯ 0.5 nmol/mg min) at 0.5 M SAPC, but it was only 25% more active than S505A at 50 M SAPC. In contrast, S505E, S707A, and S727E were almost as active as wild type regardless of SAPC concentration. One can estimate from nK d values of proteins the relative population of membrane-bound enzyme at a given [PL] 0 using Equation 3. For example, cPLA 2 and S505A should be about 98 and 93% vesicle-bound at 50 M SAPC, provided that cPLA 2 (and mutants) has similar affinities for SAPC and DHPC vesicles. Thus, 25% lower activity of S505A at this SAPC concentration should mainly derive from the difference in their catalytic efficiency. On the other hand, the difference in membrane affinity should be largely responsible for the Ͼ2-fold difference in activity seen at 0.5 M SAPC. Together, these results support the notion that cPLA 2 activation by the Ser 505 phosphorylation derives largely from enhanced membrane affinity with much smaller contribution from improved catalytic efficiency.
Ser 505 Phosphorylation and Membrane Affinity of Catalytic Domain-It has long been known that the amino-terminal C2 domain of cPLA 2 plays a pivotal role in its Ca 2ϩ -dependent membrane binding (6 -11) . We showed recently that the catalytic domain of cPLA 2 also significantly contributes to the membrane binding of cPLA 2 (20) . In particular, several hydrophobic residues in the active site rim (i.e. Ile 399 , Leu 400 , and Leu 552 ) are involved in membrane penetration and hydrophobic interactions with the membrane. Consistent with this, the full-length cPLA 2 has 5-fold higher affinity for zwitterionic DHPC vesicles than does the isolated C2 domain at 10 M Ca 2ϩ (see Table III ). We showed previously (24) that hydrophobic interactions primarily slow membrane dissociation (i.e. smaller k d ). Consistent with the hydrophobic nature of interactions between the catalytic domain of cPLA 2 and PC vesicles, the difference in affinity between the full-length cPLA 2 and the C2 domain mainly originates from the difference in k d values. Most importantly, S505A was similar to the isolated C2 domain in terms of k a , k d , and K d values (see Table III ). This suggests that the role of Ser 505 phosphorylation is to promote the favorable hydrophobic interactions between the catalytic domain of cPLA 2 and the membrane, thereby slowing its membrane dissociation and enhancing its overall membrane affinity.
To test this notion, we determined the effect of S505A mutation on the membrane binding of Ile 399 , Leu 400 , and Leu 552 . As shown in Table III , the triple-site mutation, I399A/L400A/ L552A, reduced the affinity of cPLA 2 to the level of isolated C2 domain (i.e. 5.5-fold increase in K d ), and the reduced affinity of I399A/L400A/L552A was primarily due to enhanced k d . This corroborates that these hydrophobic residues, which are involved in membrane penetration and hydrophobic interactions, cPLA 2 Phosphorylationplay a key role in the binding of the catalytic domain of cPLA 2 to PC vesicles. Intriguingly, the same hydrophobic site mutation had little effect on the membrane affinity of the S505A mutant, when the membrane binding of I399A/L400A/L552A and I399A/L400A/S505A/L552A was compared. This indicates that the three hydrophobic residues cannot effectively interact with the membrane in the Ser 505 -dephosphorylated form of cPLA 2 , which in turn supports the notion that the phosphoryl- 2؉ ] i and cellular membrane translocation of cPLA 2 and mutants upon calcium activation. The time lapse changes in EGFP intensity ratio at the nuclear membrane (ϭ nuclear membrane/(nuclear membrane ϩ cytoplasm)) for S505E-EGFP (E) and S505A-EGFP (q) and the change in [Ca 2ϩ ] i in the cytoplasm (Ⅺ) were analyzed for Fig. 3A (A) and Fig. 3B (B) .
FIG. 4. Change in [Ca
ation of Ser 505 allows the hydrophobic residues of the catalytic domain to make favorable contact with the membrane.
Because the hydrophobic interactions between the catalytic domain of cPLA 2 and the membrane are independent of Ca 2ϩ , these interactions could keep cPLA 2 on the membrane surface for some time even after the Ca 2ϩ concentration returns to a basal level. To explore this possibility, we measured the membrane translocation of wild type, S505A, and I399A/L400A/ L552A in response to a transient [Ca 2ϩ ] i increase in HEK293 cells. As described above, agonist-induced [Ca 2ϩ ] i oscillation was difficult to generate in HEK293 cells, and for this reason, we employed a non-physiologic condition in which [Ca 2ϩ ] i was raised by ionomycin and the exogenous calcium and then lowered by the exogenous addition of EGTA. When [Ca 2ϩ ] i was raised to 1.2 M, all proteins translocated to the perinuclear region (Fig. 8A) , and their membrane translocation was synchronized with the [Ca 2ϩ ] i increase (Fig. 8B) . When [Ca 2ϩ ] i was reduced to a basal level by exogenous EGTA, both S505A and I399A/L400A/L552A spontaneously migrated back to the cytoplasm. However, a large portion of the wild type cPLA 2 stayed in the perinuclear region under this condition. In fact, Ͼ60% of cPLA 2 remained in the perinuclear region for more than 10 min after [Ca 2ϩ ] i returned to a basal level. Similarly, Ͼ80% of S505E remained associated with the perinuclear membranes after [Ca 2ϩ ] i returned to a basal level (data not shown). Thus, it would seem that the Ser 505 phosphorylation-induced hydrophobic membrane binding of the catalytic domain of cPLA 2 allows the sustained membrane residence of cPLA 2 during the [Ca 2ϩ ] i oscillation, which would in turn allow its processive lipolytic action on the perinuclear membranes.
DISCUSSION
Although it has long been known that cPLA 2 is activated by phosphorylation, the elucidation of the mechanism underlying this cPLA 2 regulation has proved elusive. In particular, little progress has been made on the understanding of how each phosphorylation specifically affects cPLA 2 catalysis. A part of difficulty in this line of investigation originates from the fact that only a modest increase (i.e. Յ4-fold) in in vitro and cellular cPLA 2 activities is conferred by phosphorylation, which can be buried within the range of experimental errors depending on the assay conditions. This is notably smaller than typical responses to phosphorylation that range from 10 5 -fold activation to Ͼ10 6 -fold inhibition (33) . Furthermore, the complexity of the kinetics of interfacial catalysis has hampered the systematic analysis of the effects of phosphorylation on different steps of cPLA 2 catalysis. To elucidate the mechanism of cPLA 2 activation by phosphorylation while minimizing a complication from these problems, we separately determined kinetic and thermodynamic parameters of cPLA 2 and its phosphorylation site mutants by several independent methods under well defined conditions. In this study, we performed all in vitro kinetic and binding measurements using zwitterionic PC membranes for experimental convenience. It is expected, however, that the effects of cPLA 2 phosphorylation on its membrane affinity and enzymatic activities will be similar when cPLA 2 acts on perinuclear membranes containing PC and some anionic phospholipids (34) . This notion is supported by the finding that the relative activity of wild type and S505A remained unchanged when their enzymatic activity was measured using as substrates Functional consequences of cPLA 2 phosphorylation include the rate increase in in vitro vesicle assays (12, 30, 31, 35 ) and the enhanced agonist-induced AA release in the cell (11, 14, 15,  36 -41 ). An earlier kinetic study using cPLA 2 isolated from non-stimulated and thrombin-stimulated platelets indicated that the cPLA 2 phosphorylation increases k cat without much effect on K m and calcium sensitivity (30) . As pointed out earlier, however, these kinetic parameters determined by the Michaelis-Menten analysis bear little physical meaning in interfacial catalysis of PLA 2 . Our in vitro kinetic and binding measurements clearly show that the phosphorylation on Ser 505 has a direct effect on the membrane affinity of protein with a small but definite impact on catalytic efficiency of protein. The SPR membrane binding analysis of wild type and mutants shows that the Ser 505 phosphorylation improves the affinity of cPLA 2 for PC membrane by reducing k d (i.e. slowing membrane dissociation). It has been reported that the effect of cPLA 2 phosphorylation is manifest only at low [Ca 2ϩ ] i (14, 17, 41) . Our SPR data demonstrate that the effect of Ser 505 phosphorylation on membrane affinity of cPLA 2 is dramatically amplified at lower Ca 2ϩ concentrations. The dephosphorylated form (i.e. S505A) has only three times lower PC bilayer affinity than the phosphorylated form (i.e. S505E or wild type) at 50 M Ca 2ϩ , but the difference grows much larger (Ͼ Ͼ60 times) at 2. If the Ser 505 phosphorylation enhances the membrane affinity of cPLA 2 by reducing k d , then a question arises as to how the phosphorylation achieves this feat. Our SPR analysis of S505A and I399A/L400A/L552A clearly indicates that the phosphorylation promotes hydrophobic interactions between the aliphatic residues in the active site rim and the membrane, which result from the partial membrane penetration of these residues. It has been demonstrated that the C2 domain plays a major role in membrane targeting of cPLA 2 and that several hydrophobic residues in the C2 domain penetrate the membrane to achieve strong favorable interactions with the membrane (9, (43) (44) (45) (46) phosphorylation on membrane affinity of cPLA 2 is only modest at higher calcium concentrations. As the calcium level decreases, however, the catalytic domain would start to play a more significant role than the C2 domain in keeping the cPLA 2 molecule on the membrane surface. This notion is supported by our cell studies. The Ser 505 phosphorylation-induced hydrophobic membrane binding of the catalytic domain, due to its calcium-independent nature, allows the sustained membrane residence of cPLA 2 Systematic comparison of a large number of structures of phospho-and dephosphoproteins has revealed that the addition of dianionic phospho group(s) exerts activating or inhibitory effects by a wide variety of mechanisms (33) . Structural consequences of phosphorylation include short range and long range conformational changes caused by electrostatic attraction and repulsion, direct short range electrostatic and steric , followed by the treatment with 5 mM EGTA. B, the time lapse changes in EGFP intensity ratio at the nuclear membrane (ϭ nuclear membrane/ (nuclear membrane ϩ cytoplasm)) for cPLA 2 -EGFP (red) and S505A-EGFP (blue), I399A/L400A/L552A-EGFP (green), and the change in [Ca 2ϩ ] i in the cytoplasm (orange) were analyzed. effects without conformational changes, and interdomain association and dissociation (33) . The x-ray crystal structure of partially phosphorylated cPLA 2 suggested that two main sites of phosphorylation, Ser 505 and Ser 727 , are located near the flexible linker that connects the C2 domain and the catalytic domain (47) . In the absence of structural information on the phospho-and dephospho-cPLA 2 , it is difficult to predict the exact structural consequences of phosphorylation on Ser 505 and Ser 727 . The functional consequences of Ser 505 phosphorylation presented in this study, however, provide insights into the conformational changes conferred by the phosphorylation. On the basis of careful examination of the interdomain arrangement in the x-ray structure of cPLA 2 (47) and the reported membrane binding mode of the isolated C2 domain (9, 43, 44, 46) , we proposed that juxtaposing the active site of cPLA 2 and the membrane surface would require an interdomain conformational change involving a hinge movement of the linker region after the initial membrane binding of the C2 domain (20) . The effect of the Ser 505 phosphorylation on the membrane binding of the catalytic domain suggests that it might elicit such an interdomain movement. This movement would bring the active site close to the membrane surface, allowing the aliphatic residues in the active site rim to partially penetrate the membrane (see Fig. 9 ). The putative conformational change has a dual effect, a larger increase in affinity (i.e. at submicromolar Ca 2ϩ ) due to enhanced hydrophobic interactions, and hence longer membrane residence (or slower membrane dissociation), and a smaller (ϳ25%) increase in catalytic efficiency, presumably due to the better orientation of the active site with respect to the membrane. Finally, our finding that a glutamate side chain in S505E effectively simulates the dianionic phospho group on Ser 505 in all aspects of interfacial catalysis of cPLA 2 implies that the role of a newly incorporated phospho group is not to introduce a network of hydrogen bonds but to induce a local electrostatic effect. To test this notion, we measured the activity of wild type and S505A (15 nM each) toward 1 M [ 14 C]SAPC at 2.5 M calcium concentration with varying concentrations of NaCl. When NaCl concentration increased from 0.1 to 0.5 M, the activity of wild type increased from 150 to 350 nmol/mg⅐min, presumably due to enhanced hydrophobic membrane-cPLA 2 interactions. On the other hand, the activity of S505A increased from 60 to 300 nmol/mg⅐min. As a result, a difference in activity between wild type and S505A was much less at 0.5 M NaCl than at 0.1 M NaCl. These data support the notion that the effect of phosphorylation is mainly coulombic.
On the basis of our present data in conjunction with previous results on cPLA 2 activation, we propose a refined model for cPLA 2 activation by Ca 2ϩ and phosphorylation (see Fig. 9 ). In this model, cPLA 2 in the resting state is not fully active because of the active site lid and the suboptimal alignment of the C2 domain and the catalytic domain. Upon increasing the calcium concentration, the C2 domain drives the cPLA 2 molecule to the membrane surface, which brings the catalytic domain close to the membrane and allows removal of active site lid from the active site due to unfavorable electrostatic interactions between the lid and the membrane (20) . At this stage of interfacial catalysis, Ser 505 -phospho-cPLA 2 would productively interact with membrane phospholipids with higher affinity (due to slower membrane dissociation), whereas Ser 505 -dephosphocPLA 2 would make suboptimal contact with the membrane. However, Ser 505 phosphorylation cannot effectively activate cPLA 2 in the absence of calcium. Also, a rise in [Ca 2ϩ ] i to the submicromolar concentration, especially when it is transient, is not sufficient for full activation of cellular cPLA 2 without Ser 505 phosphorylation. Thus, the calcium mobilization and the Ser 505 phosphorylation should work in concert to regulate the amplitude and the duration of cPLA 2 activation. cPLA 2 has been found phosphorylated on Ser 505 in certain cells (11) , raising a possibility that Ser 505 is constitutively phosphorylated. It has been shown, however, that Ser 505 phosphorylation is induced in response to specific agonists in different cells (12, 16, 17) , supporting that Ser 505 phosphorylation is a true regulatory mechanism for cPLA 2 . Undoubtedly, further studies are required to fully elucidate the mechanisms of cPLA 2 regulation by phosphorylation on other sites. Nevertheless, this study and the proposed model on the Ser 505 phosphorylation should serve as a framework with which to investigate further the mechanisms by which phosphorylation on different sites regulates cPLA 2 activities. FIG. 9 . A proposed mechanism for cPLA 2 activation by calcium and phosphorylation. A, calcium ions drive the membrane translocation of the C2 domain, which brings the catalytic domain close to the membrane; however, the active site and the aliphatic residues (shown as black lobes) at the active site rim are not optimally oriented with respect to the membrane in this binding mode. B, phosphorylation on Ser 505 in the linker region induces a conformation change of the protein. When the Ser 505 -phospho-cPLA 2 binds to the membrane, the aliphatic residues (black lobes) at the active site rim partially penetrate the membrane (hence the slower membrane dissociation and enhanced affinity), and the active site is productively oriented for catalysis.
